Skip to content
GenoLensGenoLens

LAS1L

Chr Xq12

LAS1 like ribosome biogenesis factor

Aliases:
FLJ12525, Las1
MANE:
ENST00000374811.8

Annotations refreshed 9 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Moderate Evidence (Amber)

  • Intellectual disability

    X-LINKED: hemizygous mutation in males, biallelic mutations in females
  • DDG2P

    X-LINKED: hemizygous mutation in males, biallelic mutations in females
  • Hereditary neuropathy

    X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)
  • Hereditary neuropathy or pain disorder

    X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)

Disease associations (Open Targets)

  • Wilson-Turner syndrome

    0.66
  • spinal muscular atrophy with respiratory distress type 2

    0.37
  • hereditary disease

    0.30
  • Global developmental delay

    0.26
  • neurodevelopmental disorder

    0.12
  • autism spectrum disorder

    0.12
  • neurodegenerative disease

    0.10
  • cardiovascular disorder

    0.05
  • response to xenobiotic stimulus

    0.03
  • hypertensive disorder

    0.03

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Ribosomal biogenesis protein LAS1L

Required for the synthesis of the 60S ribosomal subunit and maturation of the 28S rRNA (PubMed:20647540). Functions as a component of the Five Friends of Methylated CHTOP (5FMC) complex; the 5FMC complex is recruited to ZNF148 by methylated CHTOP, leading to desumoylation of ZNF148 and subsequent transactivation of ZNF148 target genes (PubMed:22872859). Required for the efficient pre-rRNA processing at both ends of internal transcribed spacer 2 (ITS2) (PubMed:22083961)

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.